# EDGAR Filing Document

**Accession Number:** 0000052136
**File Stem:** 0001410368-25-019716
**Filing Date:** 2025-10
**Character Count:** 34058
**Document Hash:** 8f58645db68e180b0af14c3e24a8a231
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-25-019716.hdr.sgml**: 20251030

**ACCESSION NUMBER**: 0001410368-25-019716

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251030

**DATE AS OF CHANGE**: 20251030

**PERIOD START**: 20251130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Natixis Funds Trust II
- **CENTRAL INDEX KEY:** 0000052136

**ORGANIZATION NAME:**
- **EIN:** 041990692
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-00242
- **FILM NUMBER:** 251433080

**BUSINESS ADDRESS:**
- **STREET 1:** 888 BOYLSTON STREET
- **STREET 2:** 8TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02199
- **BUSINESS PHONE:** 800-283-1155

**MAIL ADDRESS:**
- **STREET 1:** 888 BOYLSTON STREET
- **STREET 2:** 8TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02199

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IXIS Advisor Funds Trust II
- **DATE OF NAME CHANGE:** 20050502

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CDC NVEST FUNDS TRUST II
- **DATE OF NAME CHANGE:** 20010503

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NVEST FUNDS TRUST II
- **DATE OF NAME CHANGE:** 20000202

## Series and Classes Contracts Data

### Loomis Sayles Global Growth Fund (Series ID: S000053353)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000167848 | Class A      | LSAGX           |
| C000167849 | Class C      | LSCGX           |
| C000167850 | Class Y      | LSGGX           |
| C000188122 | Class N      | LSNGX           |

## Nport-Ex

**Portfolio of Investments – as of August 31, 2025 (Unaudited)**

Loomis Sayles Global Growth Fund

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>**Shares**<br>| **Description** | **Value (†)** |
| **Common Stocks — 99.7% of Net Assets** | **Common Stocks — 99.7% of Net Assets** | **Common Stocks — 99.7% of Net Assets** |
|  | **Brazil — 7.8%** | **Brazil — 7.8%** |
| 802205 | Ambev SA, ADR | &nbsp;&nbsp; $1796939 |
| 3576 | MercadoLibre, Inc.(a) | &nbsp;&nbsp; 8843126 |
|  |  | &nbsp;&nbsp; 10640065 |
|  | **Canada — 5.2%** | **Canada — 5.2%** |
| 50545 | Shopify, Inc., Class A(a) | &nbsp;&nbsp; 7140998 |
|  | **China — 8.2%** | **China — 8.2%** |
| 7625 | Alibaba Group Holding Ltd., ADR(b) | &nbsp;&nbsp; 1029375 |
| 12429 | Baidu, Inc., ADR(a)(b) | &nbsp;&nbsp; 1184484 |
| 139432 | Budweiser Brewing Co. APAC Ltd. | &nbsp;&nbsp; 151201 |
| 58100 | Tencent Holdings Ltd. | &nbsp;&nbsp; 4499523 |
| 41880 | Trip.com Group Ltd., ADR(b) | &nbsp;&nbsp; 3088650 |
| 25302 | Yum China Holdings, Inc.(b) | &nbsp;&nbsp; 1131505 |
|  |  | &nbsp;&nbsp; 11084738 |
|  | **Denmark — 1.7%** | **Denmark — 1.7%** |
| 40915 | Novo Nordisk AS, Class B | &nbsp;&nbsp; 2312083 |
|  | **France — 1.4%** | **France — 1.4%** |
| 2379 | LVMH Moet Hennessy Louis Vuitton SE | &nbsp;&nbsp; 1404641 |
| 7501 | Sodexo SA | &nbsp;&nbsp; 450405 |
|  |  | &nbsp;&nbsp; 1855046 |
|  | **Japan — 1.3%** | **Japan — 1.3%** |
| 63400 | FANUC Corp. | &nbsp;&nbsp; 1762487 |
|  | **Netherlands — 4.5%** | **Netherlands — 4.5%** |
| 2556 | Adyen NV(a) | &nbsp;&nbsp; 4291958 |
| 7689 | NXP Semiconductors NV | &nbsp;&nbsp; 1805762 |
|  |  | &nbsp;&nbsp; 6097720 |
|  | **Switzerland — 1.1%** | **Switzerland — 1.1%** |
| 28804 | CRISPR Therapeutics AG(a) | &nbsp;&nbsp; 1492911 |
|  | **United Kingdom — 1.0%** | **United Kingdom — 1.0%** |
| 5575 | Reckitt Benckiser Group PLC | &nbsp;&nbsp; 416828 |
| 13950 | Unilever PLC | &nbsp;&nbsp; 878504 |
|  |  | &nbsp;&nbsp; 1295332 |
|  | **United States — 67.5%** | **United States — 67.5%** |
| 10605 | Alnylam Pharmaceuticals, Inc.(a) | &nbsp;&nbsp; 4735238 |
| 33748 | Alphabet, Inc., Class A | &nbsp;&nbsp; 7185287 |
| 32951 | Amazon.com, Inc.(a) | &nbsp;&nbsp; 7545779 |
| 15888 | ARM Holdings PLC, ADR(a) | &nbsp;&nbsp; 2197469 |
| 3732 | Autodesk, Inc.(a) | &nbsp;&nbsp; 1174460 |
| 14526 | Block, Inc.(a) | &nbsp;&nbsp; 1156851 |

---

---

| | | |
|:---|:---|:---|
| <br> **Shares**<br>| **Description** | **Value (†)** |
|  | **United States — continued** | **United States — continued** |
| 22747 | Boeing Co.(a) | &nbsp;&nbsp; $5338266 |
| 2950 | Deere & Co. | &nbsp;&nbsp; 1411988 |
| 30730 | Doximity, Inc., Class A(a) | &nbsp;&nbsp; 2087796 |
| 5470 | Expeditors International of Washington, Inc. | &nbsp;&nbsp; 659354 |
| 53279 | Experian PLC | &nbsp;&nbsp; 2761744 |
| 14047 | Meta Platforms, Inc., Class A | &nbsp;&nbsp; 10376519 |
| 10149 | Microsoft Corp. | &nbsp;&nbsp; 5142397 |
| 8324 | Nestle SA, (Registered) | &nbsp;&nbsp; 785207 |
| 6169 | Netflix, Inc.(a) | &nbsp;&nbsp; 7453694 |
| 33235 | Novartis AG, (Registered) | &nbsp;&nbsp; 4206623 |
| 29756 | Oracle Corp. | &nbsp;&nbsp; 6728724 |
| 7136 | QUALCOMM, Inc. | &nbsp;&nbsp; 1146969 |
| 5385 | Roche Holding AG | &nbsp;&nbsp; 1755931 |
| 8579 | Salesforce, Inc. | &nbsp;&nbsp; 2198369 |
| 11656 | SEI Investments Co. | &nbsp;&nbsp; 1028992 |
| 19864 | Tesla, Inc.(a) | &nbsp;&nbsp; 6631994 |
| 65613 | Under Armour, Inc., Class A(a) | &nbsp;&nbsp; 328065 |
| 5910 | Vertex Pharmaceuticals, Inc.(a) | &nbsp;&nbsp; 2310928 |
| 13620 | Visa, Inc., Class A | &nbsp;&nbsp; 4791244 |
| 4614 | Yum! Brands, Inc. | &nbsp;&nbsp; 678120 |
|  |  | &nbsp;&nbsp; 91818008 |
|  | &nbsp;&nbsp; Total Common Stocks <br>(Identified Cost $79,356,607)<br>| &nbsp;&nbsp; 135499388 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Principal** <br>**Amount**<br>|  |  |
| **Short-Term Investments — 0.3%** | **Short-Term Investments — 0.3%** | **Short-Term Investments — 0.3%** |
| $470389 | &nbsp;&nbsp; Tri-Party Repurchase Agreement with Fixed Income <br> Clearing Corporation, dated 8/29/2025 at 2.900% to be <br> repurchased at $470,541 on 9/02/2025 collateralized <br> by $468,800 U.S. Treasury Note, 4.125% <br> due 10/31/2027 valued at $479,933 including accrued <br> interest(c) <br>(Identified Cost $470,389)<br>| &nbsp;&nbsp; 470389 |
|  | &nbsp;&nbsp; Total Investments — 100.0% <br>(Identified Cost $79,826,996)<br>| &nbsp;&nbsp; 135969777 |
|  | Other assets less liabilities — (0.0)% | &nbsp;&nbsp; (9080)<br>|
|  | Net Assets — 100.0% | &nbsp;&nbsp; $135960697 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

---

| | |
|:---|:---|
| (†) | &nbsp;&nbsp;&nbsp; Registered investment companies are required to value portfolio investments using an unadjusted, readily available market quotation. The Fund obtains <br> readily available market quotations from independent pricing services. Fund investments for which readily available market quotations are not available <br> are priced at fair value pursuant to the Fund's Valuation Procedures. The Board of Trustees has approved a valuation designee who is subject to the <br> Board's oversight. <br>Unadjusted readily available market quotations that are utilized for exchange traded equity securities (including shares of closed-end investment <br> companies and exchange-traded funds) include the last sale price quoted on the exchange where the security is traded most extensively. Shares of open-<br> end investment companies are valued at net asset value ("NAV") per share. <br>Exchange traded equity securities for which there is no reported sale during the day are fair valued at the closing bid quotation as reported by an <br> independent pricing service. Unlisted equity securities (except unlisted preferred equity securities) are fair valued at the last sale price quoted in the <br> market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent <br> pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be fair valued using evaluated bids furnished <br> by an independent pricing service, if available. <br>Debt securities and unlisted preferred equity securities are fair valued based on evaluated bids furnished to the Fund by an independent pricing service or <br> bid prices obtained from broker-dealers. Broker-dealer bid prices may be used to fair value debt and unlisted equities where an independent pricing <br> service is unable to price an investment or where an independent pricing service does not provide a reliable price for the investment. <br>The Fund may also fair value investments in other circumstances such as when extraordinary events occur after the close of a foreign market, but prior to <br> the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the <br> issuer's security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions <br> or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing a Fund's investments, the valuation designee may, among other <br> things, use modeling tools or other processes that may take into account factors such as issuer specific information, or other related market activity <br> and/or information that occurred after the close of the foreign market but before the time the Fund's NAV is calculated. Fair valuation by the Fund's <br> valuation designee may require subjective determinations about the value of the investment, and fair values used to determine a Fund's NAV may differ <br> from quoted or published prices, or from prices that are used by others, for the same investments. In addition, the use of fair value pricing may not always <br> result in adjustments to the prices of investments held by a Fund. <br>The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in <br> currencies other than U.S. dollars, if any, are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period. <br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Non-income producing security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Security invests in variable interest entities based in China.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Fund may enter into repurchase agreements, under the terms of a Master Repurchase
 Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed
 upon price. It is the Fund's policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price,
 including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit
 of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the
 counterparty, including possible delays or restrictions upon the Fund's ability to dispose of the underlying securities. As of August 31, 2025, the Fund had
 an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| ADR | &nbsp;&nbsp;&nbsp; An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. <br> The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.<br>|

---

**Fair Value Measurements**

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of each Fund's assets or liabilities. These inputs are summarized in the three broad levels listed below:

&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 — quoted prices in active markets for identical assets or liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 — prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 — prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect each Fund's own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The Fund's pricing policies have been approved by the Board of Trustees. Investments for which market quotations are readily available are categorized in Level 1. Other investments for which an independent pricing service is utilized are categorized in Level 2. Broker-dealer bid prices for which the Fund has knowledge of the inputs used by the broker-dealer are categorized in Level 2. All other investments, including broker-dealer bid prices for which the Fund does not have knowledge of the inputs used by the broker-dealer, as well as investments fair valued by the valuation designee, are categorized in Level 3. All Level 2 and 3 securities are defined as being fair valued.

------

Under certain conditions and based upon specific facts and circumstances, the Fund's valuation designee may determine that a fair valuation should be made for portfolio investment(s). These valuation designee fair valuations will be based upon a significant amount of Level 3 inputs.

The following is a summary of the inputs used to value the Fund's investments as of August 31, 2025, at value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Asset Valuation Inputs** | **Asset Valuation Inputs** | **Asset Valuation Inputs** | **Asset Valuation Inputs** | **Asset Valuation Inputs** |
| Description | Level 1 | Level 2 | Level 3 | Total |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp; China | $6434014 | $4650724 | $— | $11084738 |
| &nbsp;&nbsp;&nbsp; Denmark |  | 2312083 |  | 2312083 |
| &nbsp;&nbsp;&nbsp; France |  | 1855046 |  | 1855046 |
| &nbsp;&nbsp;&nbsp; Japan |  | 1762487 |  | 1762487 |
| &nbsp;&nbsp;&nbsp; Netherlands | 1805762 | 4291958 |  | 6097720 |
| &nbsp;&nbsp;&nbsp; United Kingdom |  | 1295332 |  | 1295332 |
| &nbsp;&nbsp;&nbsp; United States | 82308503 | 9509505 |  | 91818008 |
| &nbsp;&nbsp;&nbsp; All Other Common Stocks(a) | 19273974 |  |  | 19273974 |
| Total Common Stocks | 109822253 | 25677135 |  | 135499388 |
| Short-Term Investments |  | 470389 |  | 470389 |
| Total Investments | $109822253 | $26147524 | $— | $135969777 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;(a) Details of the major categories of the Fund's investments are reflected within the Portfolio of Investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Currency Exposure Summary at August 31, 2025 (Unaudited) | Currency Exposure Summary at August 31, 2025 (Unaudited) |
| United States Dollar | 81.0<br> %<br>|
| Euro | 5.3 |
| Swiss Franc | 5.0 |
| Hong Kong Dollar | 3.4 |
| British Pound | 2.3 |
| Other, less than 2% each | 3.0 |
| Total Investments | 100.0 |
| Other assets less liabilities | (0.0)\*<br>|
| Net Assets | 100.0<br> %<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Less than 0.1%

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Natixis Funds Trust II

- **b. Investment Company Act file number:** 811-00242

- **c. CIK number of Registrant:** 0000052136

- **d. LEI of Registrant:** R4B5ZXLI2IMIOWT67V76

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 888 BOYLSTON STREET

  - **City:** BOSTON

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02199-8197

  - **Telephone number:** 617-449-2139

**Item A.2. Information about the Series.**

- **a. Name of Series:** Loomis Sayles Global Growth Fund

- **b. EDGAR series identifier (if any):** S000053353

- **c. LEI of Series:** 5493008W63EBOWG4HO71

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-11-30

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $136196939.15

**Total Liabilities:** $231050.94

**Net Assets:** $135965888.21

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000167848 | 5.18%                | 0.48%                | 3.05%                |
| Class ID C000167849 | 5.13%                | 0.37%                | 3.01%                |
| Class ID C000167850 | 5.22%                | 0.47%                | 3.08%                |
| Class ID C000188122 | 5.25%                | 0.46%                | 3.07%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $234963.61               | $6273122.68                                |
| Month 2  | $-89103.26               | $802388.93                                 |
| Month 3  | $72329.15                | $4006809.69                                |

### Schedule of Portfolio Investments

| Name                                       | Title                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| LVMH Moet Hennessy Louis Vuitton SE        | LVMH Moet Hennessy Louis Vuitton SE        | CUSIP: 000000000<br>LEI: IOG4E947OATN0KJYSD45 | Long             | EC               | CORP              | FR        |      2379 | NS      | $1404641.50   | 1.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Salesforce Inc                             | Salesforce Inc                             | CUSIP: 79466L302<br>LEI: RCGZFPDMRW58VJ54VR07 | Long             | EC               | CORP              | US        |      8579 | NS      | $2198368.75   | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                | Alnylam Pharmaceuticals Inc                | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     10605 | NS      | $4735238.55   | 3.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Expeditors International of Washington Inc | Expeditors International of Washington Inc | CUSIP: 302130109<br>LEI: 984500B055A804AB6E40 | Long             | EC               | CORP              | US        |      5470 | NS      | $659353.80    | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                 | Vertex Pharmaceuticals Inc                 | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |      5910 | NS      | $2310928.20   | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Under Armour Inc                           | Under Armour Inc                           | CUSIP: 904311107<br>LEI: 549300D4549QKWETZ406 | Long             | EC               | CORP              | US        |     65613 | NS      | $328065.00    | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Reckitt Benckiser Group PLC                | Reckitt Benckiser Group PLC                | CUSIP: 000000000<br>LEI: 5493003JFSMOJG48V108 | Long             | EC               | CORP              | GB        |      5575 | NS      | $416828.17    | 0.31%             |  |  |  | No            |                  2 | On Loan: No      |
| Alphabet Inc                               | Alphabet Inc                               | CUSIP: 02079K305<br>LEI: 5493006MHB84DD0ZWV18 | Long             | EC               | CORP              | US        |     33748 | NS      | $7185286.68   | 5.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Visa Inc                                   | Visa Inc                                   | CUSIP: 92826C839<br>LEI: 549300JZ4OKEHW3DPJ59 | Long             | EC               | CORP              | US        |     13620 | NS      | $4791243.60   | 3.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Sodexo SA                                  | Sodexo SA                                  | CUSIP: 000000000<br>LEI: 969500LCBOG12HXPYM84 | Long             | EC               | CORP              | FR        |      7501 | NS      | $450404.53    | 0.33%             |  |  |  | No            |                  2 | On Loan: No      |
| Roche Holding AG                           | Roche Holding AG                           | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |      5385 | NS      | $1755930.93   | 1.29%             |  |  |  | No            |                  2 | On Loan: No      |
| Alibaba Group Holding Ltd                  | Alibaba Group Holding Ltd                  | CUSIP: 01609W102<br>LEI: 5493001NTNQJDH60PM02 | Long             | EC               | CORP              | KY        |      7625 | NS      | $1029375.00   | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| NXP Semiconductors NV                      | NXP Semiconductors NV                      | CUSIP: 000000000<br>LEI: 724500M9BY5293JDF951 | Long             | EC               | CORP              | NL        |      7689 | NS      | $1805761.65   | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Block Inc                                  | Block Inc                                  | CUSIP: 852234103<br>LEI: 549300OHIIUWSTIZME52 | Long             | EC               | CORP              | US        |     14526 | NS      | $1156850.64   | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                           | Novo Nordisk A/S                           | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |     40915 | NS      | $2312082.56   | 1.70%             |  |  |  | No            |                  2 | On Loan: No      |
| Microsoft Corp                             | Microsoft Corp                             | CUSIP: 594918104<br>LEI: INR2EJN1ERAN0W5ZP974 | Long             | EC               | CORP              | US        |     10149 | NS      | $5142396.81   | 3.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Adyen NV                                   | Adyen NV                                   | CUSIP: 000000000<br>LEI: 724500973ODKK3IFQ447 | Long             | EC               | CORP              | NL        |      2556 | NS      | $4291958.48   | 3.16%             |  |  |  | No            |                  2 | On Loan: No      |
| ARM Holdings PLC                           | ARM Holdings PLC                           | CUSIP: 042068205<br>LEI: 2138001E66EELTE7Y904 | Long             | EC               | CORP              | GB        |     15888 | NS      | $2197469.28   | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                     | CRISPR Therapeutics AG                     | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |     28804 | NS      | $1492911.32   | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Doximity Inc                               | Doximity Inc                               | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30730 | NS      | $2087796.20   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Nestle SA                                  | Nestle SA                                  | CUSIP: 000000000<br>LEI: KY37LUS27QQX7BB93L28 | Long             | EC               | CORP              | CH        |      8324 | NS      | $785207.42    | 0.58%             |  |  |  | No            |                  2 | On Loan: No      |
| Netflix Inc                                | Netflix Inc                                | CUSIP: 64110L106<br>LEI: 549300Y7VHGU0I7CE873 | Long             | EC               | CORP              | US        |      6169 | NS      | $7453694.25   | 5.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Unilever PLC                               | Unilever PLC                               | CUSIP: 000000000<br>LEI: 549300MKFYEKVRWML317 | Long             | EC               | CORP              | GB        |     13950 | NS      | $878504.38    | 0.65%             |  |  |  | No            |                  2 | On Loan: No      |
| FANUC Corp                                 | FANUC Corp                                 | CUSIP: 000000000<br>LEI: 529900QTSW745LOKW705 | Long             | EC               | CORP              | JP        |     63400 | NS      | $1762487.41   | 1.30%             |  |  |  | No            |                  2 | On Loan: No      |
| Tesla Inc                                  | Tesla Inc                                  | CUSIP: 88160R101<br>LEI: 54930043XZGB27CTOV49 | Long             | EC               | CORP              | US        |     19864 | NS      | $6631993.68   | 4.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Yum China Holdings Inc                     | Yum China Holdings Inc                     | CUSIP: 98850P109<br>LEI: 529900DO9BYZ7VA3K502 | Long             | EC               | CORP              | US        |     25302 | NS      | $1131505.44   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Budweiser Brewing Co APAC Ltd              | Budweiser Brewing Co APAC Ltd              | CUSIP: 000000000<br>LEI: 549300YF1MR4GTF18132 | Long             | EC               | CORP              | KY        |    139432 | NS      | $151200.67    | 0.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Ambev SA                                   | Ambev SA                                   | CUSIP: 02319V103<br>LEI: 549300TH5Q6VRP8OT012 | Long             | EC               | CORP              | BR        |    802205 | NS      | $1796939.20   | 1.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Trip.com Group Ltd                         | Trip.com Group Ltd                         | CUSIP: 89677Q107<br>LEI: 2549004RMYDSRQL4KW41 | Long             | EC               | CORP              | KY        |     41880 | NS      | $3088650.00   | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Deere & Co                                 | Deere & Co                                 | CUSIP: 244199105<br>LEI: PWFTNG3EI0Y73OXWDH08 | Long             | EC               | CORP              | US        |      2950 | NS      | $1411988.00   | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Meta Platforms Inc                         | Meta Platforms Inc                         | CUSIP: 30303M102<br>LEI: BQ4BKCS1HXDV9HN80Z93 | Long             | EC               | CORP              | US        |     14047 | NS      | $10376518.90  | 7.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Oracle Corp                                | Oracle Corp                                | CUSIP: 68389X105<br>LEI: 1Z4GXXU7ZHVWFCD8TV52 | Long             | EC               | CORP              | US        |     29756 | NS      | $6728724.28   | 4.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Experian PLC                               | Experian PLC                               | CUSIP: 000000000<br>LEI: 635400RXXHHYT1JTSZ26 | Long             | EC               | CORP              | JE        |     53279 | NS      | $2761744.29   | 2.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Boeing Co/The                              | Boeing Co/The                              | CUSIP: 097023105<br>LEI: RVHJWBXLJ1RFUBSY1F30 | Long             | EC               | CORP              | US        |     22747 | NS      | $5338265.96   | 3.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Autodesk Inc                               | Autodesk Inc                               | CUSIP: 052769106<br>LEI: FRKKVKAIQEF3FCSTPG55 | Long             | EC               | CORP              | US        |      3732 | NS      | $1174460.40   | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Baidu Inc                                  | Baidu Inc                                  | CUSIP: 056752108<br>LEI: 254900AL64IANZYI1E02 | Long             | EC               | CORP              | KY        |     12429 | NS      | $1184483.70   | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Yum! Brands Inc                            | Yum! Brands Inc                            | CUSIP: 988498101<br>LEI: 549300JE8XHZZ7OHN517 | Long             | EC               | CORP              | US        |      4614 | NS      | $678119.58    | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Fixed Income Clearing Corp                 | FIXED INC CLEARING CORP.REPO               | CUSIP: 000000000<br>LEI: 549300H47WTHXPU08X20 | Long             | RA               | CORP              | US        |    470389 | PA      | $470389.00    | 0.35%             |  |  |  | No            |                  2 | On Loan: No      |
| QUALCOMM Inc                               | QUALCOMM Inc                               | CUSIP: 747525103<br>LEI: H1J8DDZKZP6H7RWC0H53 | Long             | EC               | CORP              | US        |      7136 | NS      | $1146969.28   | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Shopify Inc                                | Shopify Inc                                | CUSIP: 82509L107<br>LEI: 549300HGQ43STJLLP808 | Long             | EC               | CORP              | CA        |     50545 | NS      | $7140997.60   | 5.25%             |  |  |  | No            |                  1 | On Loan: No      |
| MercadoLibre Inc                           | MercadoLibre Inc                           | CUSIP: 58733R102<br>LEI: 549300DKPDN9M5S8GB14 | Long             | EC               | CORP              | US        |      3576 | NS      | $8843126.16   | 6.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                                | Novartis AG                                | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |     33235 | NS      | $4206622.55   | 3.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Tencent Holdings Ltd                       | Tencent Holdings Ltd                       | CUSIP: 000000000<br>LEI: 254900N4SLUMW4XUYY11 | Long             | EC               | CORP              | KY        |     58100 | NS      | $4499522.81   | 3.31%             |  |  |  | No            |                  2 | On Loan: No      |
| Amazon.com Inc                             | Amazon.com Inc                             | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |     32951 | NS      | $7545779.00   | 5.55%             |  |  |  | No            |                  1 | On Loan: No      |
| SEI Investments Co                         | SEI Investments Co                         | CUSIP: 784117103<br>LEI: 5LJTIFADGZ6XH1RVOC11 | Long             | EC               | CORP              | US        |     11656 | NS      | $1028991.68   | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-09-30

**Name of Applicant:** Natixis Funds Trust II

**Signature:** John Sgroi

**Name of Signer:** John Sgroi

**Title:** Assistant Treasurer